Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug development

Nat Immunol. 2019 Nov;20(11):1556. doi: 10.1038/s41590-019-0531-x.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

  • Published Erratum